Gina Tumino Bellistri

Gina Tumino Bellistri has a strong background in clinical outsourcing and vendor management within the pharmaceutical industry. Gina'smost recent role is as the Bioassay Operations Lead at the Bill & Melinda Gates Medical Research Institute, starting in 2022. Prior to that, they worked as a Clinical Outsourcing Consultant at Syros Pharmaceuticals from 2021 to 2022. Gina also served as the Director of Clinical Outsourcing at CRISPR Therapeutics from 2018 to 2021 and as the Director of Clinical Vendor Management at Agenus from 2017 to 2018.

Before that, Gina held various senior positions at Shire, Baxalta, inVentiv Health Clinical, Randstad USA, ICON Central Laboratories, and Sepracor Inc, where they played key roles in managing and standardizing clinical development outsourcing, improving outsourcing tools and processes, integrating companies during acquisitions, developing efficient practices, establishing preferred provider relationships, and overseeing vendor relationships and operational standards. Gina's expertise lies in optimizing clinical outsourcing and vendor management to drive operational excellence and strategic partnerships.

Gina Tumino Bellistri holds a Bachelor of Science (BS) degree in Medical Technology from Fitchburg State University. In addition to their educational background, they have obtained certifications in Strategic Partnerships from LinkedIn in April 2021 and Communication Foundations from LinkedIn in November 2020. Gina also holds the MT(ASCP) certification, although the institution and specific date of attainment are unknown.